Accuray (ARAY) Non-Current Assets (2011 - 2026)
Accuray's (ARAY) quarterly Non-Current Assets came in at $154.4 million in Q1 2026, up 839.89% year-on-year from $16.4 million in Q1 2025, and up 923.03% quarter-over-quarter from $15.1 million in Q4 2025.
Accuray (ARAY) Non-Current Assets (2011 - 2026) Analysis & Trends
Accuray's Non-Current Assets history runs 16 years deep, the most recent figure standing at $154.4 million for Q1 2026.
- On a quarterly basis, Non-Current Assets rose 839.89% year-over-year to $154.4 million in Q1 2026; TTM through Mar 2026 was $512.0 million, a 3016.83% increase from a year earlier, with the FY2025 full-year figure at $15.5 million, up 34.09% from the prior year.
- Non-Current Assets climbed to $154.4 million in Q1 2026 per ARAY's latest filing, from $15.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $154.4 million in Q1 2026 and bottomed at $11.6 million in Q2 2024.
- The 5-year median for Non-Current Assets is $15.5 million (2025), against an average of $23.9 million.
- Across the five-year window, Non-Current Assets decreased 27.19% in 2023 and soared 839.89% in 2026, its largest moves.
- Year by year, Non-Current Assets stood at $17.4 million in 2022, then declined by 22.73% to $13.4 million in 2023, then advanced by 19.27% to $16.0 million in 2024, then declined by 5.7% to $15.1 million in 2025, then surged by 923.03% to $154.4 million in 2026.
- Per Business Quant, the three latest ARAY Non-Current Assets figures stand at $154.4 million (Q1 2026), $15.1 million (Q4 2025), and $15.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | 154.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 154.39 Mn |
| Dec 31, 2025 | 15.09 Mn |
| Sep 30, 2025 | 15.11 Mn |
| Jun 30, 2025 | 15.53 Mn |
| Mar 31, 2025 | 16.43 Mn |
| Dec 31, 2024 | 16.00 Mn |
| Sep 30, 2024 | 15.01 Mn |
| Jun 30, 2024 | 11.58 Mn |
| Mar 31, 2024 | 12.43 Mn |
| Dec 31, 2023 | 13.42 Mn |
| Sep 30, 2023 | 13.58 Mn |
| Jun 30, 2023 | 14.35 Mn |
| Mar 31, 2023 | 16.50 Mn |
| Dec 31, 2022 | 17.36 Mn |
| Sep 30, 2022 | 17.66 Mn |
| Jun 30, 2022 | 19.70 Mn |
| Mar 31, 2022 | 21.75 Mn |
| Dec 31, 2021 | 22.14 Mn |
| Sep 30, 2021 | 22.68 Mn |
| Jun 30, 2021 | 22.76 Mn |